This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)
C3_PANCREAS_ADENO_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
940 |
4. Check minimum number of eventsNone |
940 |
5. Include endpointsNone |
940 |
6. Filter based on genotype QC (FinnGen only) |
940 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Adenocarcinoma of pancreas
- Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
- Adenocarcinoma and ductal carcinoma of pancreas
- Malignant neoplasm of pancreas
- Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 940 | 394 | 546 |
| Unadjusted period prevalence (%) | 0.20 | 0.13 | 0.24 |
| Median age at first event (years) | 70.32 | 69.90 | 70.62 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 861
- Matched controls
- 8608
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
323.0
374
*
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
590
*
A04AA02
ATC
granisetron; systemic, transdermal
4726.3
323.0
321
*
A03FA01
ATC
metoclopramide; systemic, rectal
25.5
323.0
519
484
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
323.0
581
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
323.0
537
*
H02AB02
ATC
dexamethasone; systemic
124.7
309.7
322
41
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
107.2
288.3
306
44
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
288.2
260
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
92.4
271.2
294
48
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
166.6
262.2
266
23
Z51.5
ICD-10 Finland
Palliative care
45.2
239.9
297
99
N02AA05
ATC
oxycodone; systemic
14.4
225.6
444
594
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
220.6
202
*
L01BC06
ATC
capecitabine; oral
+∞
196.6
181
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
196.6
181
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
2273.6
186.5
174
*
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
+∞
177.4
164
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
172.9
160
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
143.9
134
*
UJK02
NOMESCO Finland
ERCP
28.8
142.0
196
87
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
79.7
140.6
157
24
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
85.5
134.7
149
21
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
132.8
124
*
K83.1
ICD-10 Finland
Obstruction of bile duct
62.9
130.4
151
29
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
487.0
129.6
126
*
JN4BD
NOMESCO Finland
Extensive body CT
14.6
125.1
223
201
WX302
NOMESCO Finland
Thoracal epidural anesthesy
34.2
121.8
160
57
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
116.3
109
*
A04AA01
ATC
ondansetron; systemic, rectal
28.6
113.2
156
66
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
18.4
104.0
166
110
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
47.1
100.0
122
30
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
62.2
93.9
109
20
JN4CD
NOMESCO Finland
Very extensive body CT
32.4
92.6
123
44
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
927.7
87.2
84
*
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
87.0
82
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.8
83.2
355
1104
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
854.6
80.8
78
*
JN4AD
NOMESCO Finland
Body CT examination
14.5
79.4
139
113
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
25.3
72.6
103
46
R4190
NOMESCO Finland
Nutritional therapy
28.5
72.3
99
39
L03AA02
ATC
filgrastim; parenteral
161.6
71.2
74
5
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
68.7
65
*
8140/3-C25.2
ICD-O-3
Adenocarcinoma, NOS, of tail of pancreas
+∞
66.5
63
*
D76
ICPC
Malignant neoplasm pancreas
688.4
65.8
64
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.5
63.8
130
143
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
21.8
63.4
94
48
WZC30
NOMESCO Finland
Teaching
6.1
62.8
189
379
TPX10
NOMESCO Finland
Implantation of vascular injection port
18.5
61.2
96
58
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
60.1
57
*
JAH01
NOMESCO Finland
Laparoscopy
14.9
59.1
101
76
JDE00
NOMESCO Finland
Gastrojejunostomy
214.6
58.8
60
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.6
58.8
86
42
A06AH03
ATC
naloxegol; oral
111.2
57.6
62
6
A04AA55
ATC
palonosetron, combinations; systemic
+∞
55.8
53
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
54.8
52
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
124.2
54.5
58
5
B01AB10
ATC
tinzaparin; parenteral
9.3
53.6
116
141
L03AA13
ATC
pegfilgrastim; parenteral
+∞
52.6
50
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
32.5
52.4
69
23
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
51.3
202
538
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
270.7
50.6
51
*
8140/3-C25.1
ICD-O-3
Adenocarcinoma, NOS, of body of pancreas
+∞
49.4
47
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
48.4
46
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
39.5
46.9
59
16
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
11.2
46.3
90
89
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
45.0
163
394
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
43.1
41
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
438.2
42.5
42
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.9
42.4
111
180
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
42.0
40
*
R50.9
ICD-10 Finland
Fever, unspecified
3.9
40.7
187
565
B01AB05
ATC
enoxaparin; parenteral
2.9
39.6
326
1511
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.1
39.5
135
304
JLC10
NOMESCO Finland
Distal pancreatectomy
405.1
39.4
39
*
WW500
NOMESCO Finland
Blood transfusion
10.4
38.8
78
82
JMA10
NOMESCO Finland
Transabdominal total splenectomy
139.6
38.0
40
*
A98
ICPC
Health maint/preventive medicine
0.4
38.0
478
6614
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
36.7
35
*
R18
ICD-10 Finland
Ascites
17.9
36.3
57
34
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
193.0
36.0
37
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
35.4
161
477
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
99.3
35.0
38
*
K83.0
ICD-10 Finland
Cholangitis
12.7
34.9
63
53
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
34.6
33
*
191
Kela drug reimbursment
Erlotinib
+∞
33.6
32
*
JAH00
NOMESCO Finland
Laparotomy
10.1
33.2
67
71
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
77.4
33.1
37
5
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
28.9
32.7
44
16
C61
ICD-10 Finland
Malignant neoplasm of prostate
62.5
31.3
36
6
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.1
30.9
130
357
A04AD12
ATC
aprepitant; systemic
+∞
30.4
29
*
L01XE03
ATC
[U] erlotinib; oral
+∞
29.3
28
*
J01MA12
ATC
levofloxacin; systemic
2.8
29.0
225
970
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
301.7
28.9
29
*
WF002
NOMESCO Finland
Radical radiotherapy
66.3
28.1
32
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
28.0
228
1011
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
27.2
26
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
28.0
25.9
35
13
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.7
25.8
53
58
JN3AD
NOMESCO Finland
Abdominal CT examination
4.2
25.7
103
269
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
257.2
24.8
25
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
24.4
80
170
115
Kela drug reimbursment
Breast cancer
+∞
24.1
23
*
A79
ICPC
Malignancy NOS
89.3
23.8
26
*
A06AD11
ATC
lactulose; oral
2.6
23.6
200
897
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
23.2
121
394
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
23.0
22
*
A10AE04
ATC
insulin glargine; parenteral
3.1
22.5
139
509
N02AA01
ATC
morphine; systemic, rectal
16.3
22.5
36
23
N02AX02
ATC
tramadol; systemic, rectal
2.1
22.3
402
2563
A02BC02
ATC
pantoprazole; systemic
2.1
22.2
559
4078
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
29.9
22.0
29
10
1570A
ICD-9 Finland
Malignant neoplasm of pancreas, Head of pancreas
+∞
22.0
21
*
116
Kela drug reimbursment
Prostate cancer
+∞
22.0
21
*
1CD01
NOMESCO Finland
NA
+∞
22.0
21
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
82.3
21.8
24
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
118.0
21.7
23
*
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
9.1
21.3
45
52
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
20.0
20.9
31
16
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
20.9
20
*
ZX120
NOMESCO Finland
Intravenous
3.6
20.9
98
293
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
9.5
20.5
42
46
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
19.9
19
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
19.6
291
1689
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
28.5
18.8
25
9
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
30.8
18.4
24
8
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
18.3
157
700
TJA10
NOMESCO Finland
Laparocentesis
+∞
17.8
17
*
JLA00
NOMESCO Finland
Exploration of pancreas
+∞
17.8
17
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
17.8
17
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
17.8
17
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
17.5
208
1085
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
29.5
17.5
23
8
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
51.1
17.0
20
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
16.9
76
219
PJA12
NOMESCO Finland
Sentinel node biopsy
64.7
16.8
19
*
JLA10
NOMESCO Finland
Biopsy of pancreas
173.2
16.5
17
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.4
16.5
99
2009
WX004
NOMESCO Finland
Patient-controlled sedation
18.9
16.1
24
13
B01AB04
ATC
dalteparin; parenteral
4.0
15.9
64
168
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
61.2
15.8
18
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
TPX15
NOMESCO Finland
Removal of vascular injection port
+∞
15.7
15
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
15.7
15
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
19.6
15.6
23
12
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
9.7
15.5
31
33
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.4
14.8
77
1656
ZX122
NOMESCO Finland
Intra-arterial
18.8
14.7
22
12
K85.8
ICD-10 Finland
Other acute pancreatitis
18.8
14.7
22
12
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
25.5
14.7
20
8
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
14.6
14
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
14.6
14
*
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
14.6
14
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.9
14.3
28
29
K86.1
ICD-10 Finland
Other chronic pancreatitis
12.2
14.1
25
21
N06DX01
ATC
memantine; oral
0.1
14.1
6
510
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.4
13.9
87
1748
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
13.6
71
231
ZX121
NOMESCO Finland
Central venous catheter
76.4
13.6
15
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
76.4
13.6
15
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.3
13.6
37
1043
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
+∞
13.6
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
142.1
13.5
14
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
142.1
13.5
14
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
13.4
55
147
A41.8
ICD-10 Finland
Other specified sepsis
7.2
13.4
32
46
WX402
NOMESCO Finland
General anaesthesia
2.5
13.3
111
484
P20
ICPC
Memory disturbance
0.3
13.0
30
913
WX002
NOMESCO Finland
Sedation and analgesia
2.0
13.0
181
1001
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
12.8
107
465
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
12.6
152
2495
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
12.5
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
131.8
12.5
13
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
12.1
160
864
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.1
12.1
16
6
C10AA05
ATC
atorvastatin; oral
0.6
12.0
178
2767
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.5
11.9
109
1950
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
7.0
11.7
28
41
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.5
11.7
107
1913
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
65.9
11.6
13
*
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
11.6
272
3776
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
11.5
250
1605
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
11.5
11
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
11.5
11
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
121.6
11.5
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
25.4
11.2
15
6
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.3
11.0
33
894
C10AA07
ATC
rosuvastatin; oral
0.5
10.9
76
1487
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
10.8
137
722
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
60.8
10.6
12
*
SPAT1053
SPAT
Memory test
0.4
10.6
51
1141
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
10.6
8
458
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
10.5
280
1907
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
10.5
228
3245
HAC20
NOMESCO Finland
Total mastectomy
111.3
10.4
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
111.3
10.4
11
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
JKD00
NOMESCO Finland
Anastomosis of gallbladder to jejunum
+∞
10.4
10
*
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
+∞
10.4
10
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.4
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
10.4
10
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
10.4
10
*
C25.7
ICD-10 Finland
Malignant neoplasm: Other parts of pancreas
+∞
10.4
10
*
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
10.4
10
*
N05AD01
ATC
haloperidol; systemic
3.4
10.4
49
149
J94.8
ICD-10 Finland
Other specified pleural conditions
5.9
10.3
28
49
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
10.2
123
2040
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.7
9.7
42
119
M79.6
ICD-10 Finland
Pain in limb
0.5
9.6
114
1902
R83
ICPC
Respiratory infection other
0.3
9.5
23
692
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.9
9.5
38
101
ZX090
NOMESCO Finland
Other technic of radiotherapy
101.1
9.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
101.1
9.4
10
*
L02BB03
ATC
bicalutamide; oral
101.1
9.4
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
30.4
9.4
12
*
I50.9
ICD-10 Finland
Heart failure, unspecified
0.4
9.4
57
1176
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
9.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
9.4
9
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
9.4
9
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
9.4
9
*
WX320
NOMESCO Finland
Spinalanesthesy
0.5
9.4
65
1278
C10AX09
ATC
ezetimibe; oral
0.3
9.3
19
616
Z01.2
ICD-10 Finland
Dental examination
0.5
9.3
110
1840
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
9.3
108
1814
F03
ICD-10 Finland
Unspecified dementia
0.1
9.3
*
335
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.4
9.3
21
29
207
Kela drug reimbursment
Chronic arrhythmias
0.4
9.2
51
1088
I81
ICD-10 Finland
Portal vein thrombosis
15.8
9.0
14
9
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.6
8.7
123
1967
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
8.6
170
2504
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
8.6
34
823
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
8.3
8.6
18
22
B01AC04
ATC
clopidogrel; oral
0.5
8.6
59
1168
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.4
8.5
19
26
L02BA01
ATC
tamoxifen; oral
90.9
8.4
9
*
A21
ICPC
Risk factor for malignancy
+∞
8.3
8
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
V03AF03
ATC
calcium folinate; systemic
+∞
8.3
8
*
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
+∞
8.3
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.3
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
8.3
8
*
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
9.6
8.3
16
17
R5140
NOMESCO Finland
Monitoring the use of the aid
0.3
8.3
14
500
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
8.2
371
4606
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.1
8.2
21
35
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
33.7
8.1
10
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
8.1
46
160
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.4
8.0
28
711
N06DA03
ATC
rivastigmine; oral, transdermal
0.1
8.0
*
278
M25.5
ICD-10 Finland
Pain in joint
0.5
7.9
72
1306
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.9
344
2613
G04BD12
ATC
mirabegron; oral
0.3
7.8
17
534
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
7.7
190
2675
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.6
7.6
33
95
CJB10
NOMESCO Finland
Laser discission of secondary cataract
0.3
7.6
16
513
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
7.6
203
2816
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.8
7.5
46
170
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
80.8
7.4
8
*
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
80.8
7.4
8
*
AA1AD
NOMESCO Finland
CT of head and brain
0.6
7.4
92
1530
B01AF02
ATC
apixaban; oral
0.3
7.3
22
601
K02.1
ICD-10 Finland
Caries of dentine
0.6
7.3
197
2730
1571A
ICD-9 Finland
Malignant neoplasm of pancreas, Body of pancreas
+∞
7.3
7
*
L01BC04
ATC
carmofur; oral
+∞
7.3
7
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
7.3
7
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
+∞
7.3
7
*
6706
FHL
Pancreatic homeectomy (eg Whipple)
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
+∞
7.3
7
*
R11
ICD-10 Finland
Nausea and vomiting
2.3
7.3
65
294
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
7.3
10
401
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
7.2
104
1666
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.3
7.2
34
105
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
15.9
7.2
11
7
H26.4
ICD-10 Finland
After-cataract
0.4
7.2
23
611
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.3
7.2
21
579
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.4
7.2
16
22
JFC00
NOMESCO Finland
Entero-enterostomy
30.3
7.2
9
*
N07BC02
ATC
methadone; systemic
30.3
7.2
9
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.3
7.0
12
429
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
5.0
7.0
21
43
N05AX08
ATC
risperidone; systemic
0.3
7.0
15
473
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
7.0
101
1616
L15
ICPC
Knee symptom/complaint
0.5
6.9
58
1080
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.1
6.9
25
62
WX882
NOMESCO Finland
High dependency care
3.5
6.9
30
88
R42
ICD-10 Finland
Dizziness and giddiness
0.6
6.9
82
1380
L13
ICPC
Hip symptom/complaint
0.5
6.9
45
907
JKA20
NOMESCO Finland
Cholecystectomy
2.9
6.8
39
138
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
22.7
6.7
9
*
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
22.7
6.7
9
*
K31.5
ICD-10 Finland
Obstruction of duodenum
22.7
6.7
9
*
WX704
NOMESCO Finland
Intubation
2.5
6.7
50
208
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
6.5
100
1580
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
0.1
6.5
*
192
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.5
65
313
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.4
6.4
32
709
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
70.3
6.4
7
*
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
70.3
6.4
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
70.3
6.4
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
70.3
6.4
7
*
Y77
ICPC
Malignant neoplasm prostate
70.3
6.4
7
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.5
6.4
14
19
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.4
6.4
25
608
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.3
228
1639
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
0.0
6.3
*
161
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
6.3
156
2215
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
11.1
6.3
11
10
2390A
ICD-9 Finland
Neoplasm of unspecified nature, Digestive system
11.1
6.3
11
10
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
11.1
6.3
11
10
N06DA02
ATC
donepezil; oral
0.3
6.3
14
434
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.6
6.3
171
2377
6672
FHL
Cholecocenterostomy
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
PHC71
NOMESCO Finland
Suture of mesenteric or portal vein
+∞
6.3
6
*
1579X
ICD-9 Finland
Malignant neoplasm of pancreas, Pancreas, part unspecified
+∞
6.3
6
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
6.3
6
*
325
Kela drug reimbursment
Erlotinib
+∞
6.3
6
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
6.3
6
*
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
6.3
6
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.5
6.2
39
800
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.3
6.2
15
24
WVA20
NOMESCO Finland
Medicine administration
4.1
6.1
22
55
C07AB07
ATC
bisoprolol; oral
0.7
6.1
288
3625
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.2
6.1
30
97
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
6.1
23
60
XCW99
NOMESCO Finland
Other investigative procedure of eye
0.4
6.1
25
600
KA1FN
NOMESCO Finland
Isotope renography
12.6
6.1
10
8
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.2
6.1
6
289
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.4
6.0
21
536
C01DA14
ATC
isosorbide mononitrate; oral
0.6
6.0
92
1457
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
489
389
25.12
307.65
7.3
1.4
ug/l
142.6
3.8
1.52
468
292
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
223
80
36.23
307.65
8.1
1.6
u/ml
7696.8
66.8
3.10
213
72
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
319
138
34.48
307.65
7.8
1.9
u/ml
35479.7
101.5
1.14
291
107
(3000570) Elastase.pancreatic [Mass/mass] in Stool
249
177
18.78
284.73
1.6
1.3
ug/g
143.4
297.1
14.75
134
108
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
105
27
43.65
174.06
1.2
1.3
—
—
—
0
0
(4035726)
167
176
11.32
146.59
1.2
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
259
569
5.90
117.27
4.0
1.8
g/l
0.2
0.2
3.00
245
512
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
278
677
5.41
111.67
5.9
2.2
umol/l
41.9
8.9
13.20
255
584
(40768441) Liver Pathology biopsy report
69
24
30.95
104.22
1.0
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
478
2172
3.44
75.99
6.0
2.2
u/l
45.9
58.0
5.83
457
1975
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
445
7021
0.30
70.22
3.5
5.5
mmol/l
2.6
2.6
0.28
368
6359
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
415
6750
0.31
67.78
3.3
4.9
mmol/l
1.4
1.4
2.99
338
6093
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
425
6827
0.31
67.64
3.2
4.9
mmol/l
4.5
4.5
0.11
345
6210
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
412
6528
0.34
56.23
3.1
4.3
mmol/l
1.3
1.3
0.79
337
5830
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
465
6927
0.35
54.46
3.8
5.1
mmol/l
7.0
6.1
12.16
397
6190
(3023368) Bacteria identified in Blood by Culture
419
2061
2.86
53.23
7.4
4.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
184
572
3.76
50.67
9.0
2.1
u/l
46.5
37.2
0.54
169
464
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
408
6342
0.37
48.45
3.4
4.7
mu/l
2.1
2.2
0.18
332
5662
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
455
6691
0.38
46.12
6.9
6.7
mmol/mol
45.8
41.1
11.31
408
6122
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
554
3411
2.52
41.29
26.7
3.7
umol/l
22.6
12.2
6.77
538
3185
(3000963) Hemoglobin [Mass/volume] in Blood
582
7558
0.40
38.85
54.2
21.1
g/l
116.6
134.5
127.74
561
7383
(3010813) Leukocytes [#/volume] in Blood
582
7557
0.40
38.80
53.7
21.0
e9/l
8.0
6.8
15.70
553
7251
(3026361) Erythrocytes [#/volume] in Blood
582
7556
0.40
38.74
53.7
21.0
e12/l
3.9
4.4
84.63
555
7247
(3024731) MCV [Entitic volume]
582
7555
0.40
38.68
53.6
20.9
fl
91.3
91.7
1.06
564
7382
(3007461) Platelets [#/volume] in Blood
582
7555
0.40
38.68
53.8
21.0
e9/l
262.5
240.0
7.82
558
7284
(3035941) MCH [Entitic mass]
582
7555
0.40
38.68
53.5
20.9
pg
30.1
30.5
6.25
564
7382
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
309
5180
0.40
37.85
2.9
3.7
pmol/l
14.9
15.1
0.56
254
4605
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
369
1977
2.43
36.11
6.6
2.6
u/l
63.6
34.3
10.14
355
1872
(3024561) Albumin [Mass/volume] in Serum or Plasma
497
3063
2.32
34.83
13.2
3.6
g/l
30.4
35.0
49.60
480
2814
(3023103) Potassium [Moles/volume] in Serum or Plasma
578
7375
0.44
31.05
41.4
17.8
mmol/l
4.0
4.0
5.26
557
7139
(3019550) Sodium [Moles/volume] in Serum or Plasma
578
7357
0.44
30.22
41.4
17.7
mmol/l
137.3
139.7
49.69
557
7131
(3012095) Magnesium [Moles/volume] in Serum or Plasma
223
1024
2.54
29.70
3.6
2.5
mmol/l
0.8
0.8
1.52
209
933
(3044640) Blood type and Crossmatch panel - Blood
352
1985
2.24
29.24
3.5
2.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
574
7298
0.45
29.01
29.8
9.3
u/l
44.5
24.9
23.22
555
6942
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
34
37
9.50
28.41
1.5
1.3
ug/l
15.9
15.7
0.04
34
37
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
472
6417
0.47
28.17
40.9
13.3
ml/min/173m2
83.4
72.9
22.16
421
5169
(3033658) Prothrombin time (PT) actual/Normal
295
1608
2.22
26.11
7.5
3.5
%
76.9
83.0
4.41
289
1558
(3032080) INR in Blood by Coagulation assay
478
3132
2.07
26.06
10.4
11.4
inr
1.2
1.4
4.09
136
842
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
48
88
5.69
25.29
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
84
246
3.65
24.66
2.4
2.6
u/ml
0.3
0.4
1.60
52
147
(40761511) CBC panel - Blood by Automated count
560
7053
0.49
23.77
34.0
14.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
261
1412
2.17
23.13
10.9
2.2
mmol/l
2.5
2.4
10.76
253
1201
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
65
1913
0.29
22.57
1.4
1.6
mmol/l
1.5
1.3
0.30
60
1581
(3013707) Erythrocyte sedimentation rate by Westergren method
366
5195
0.52
20.85
3.0
4.2
mm/h
19.5
13.4
7.47
327
4729
(3003338) MCHC [Mass/volume]
411
5587
0.53
19.74
50.1
19.2
g/l
328.8
331.7
9.91
405
5525
(3042936) Bacteria identified in Isolate by Culture
198
1027
2.18
19.12
2.1
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
498
3610
1.81
17.37
27.1
5.9
e9/l
4.7
4.4
1.35
467
3089
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
19
18
10.75
17.37
2.2
1.2
umol/l
26.5
28.5
0.35
19
18
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
127
2464
0.44
16.83
1.9
2.2
u/l
135.8
246.4
1.40
115
2302
(3002256) Pathology report gross observation
107
451
2.55
16.51
1.6
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
347
2308
1.80
15.74
10.7
2.1
mmol/l
2.3
2.3
6.09
330
1871
(40768804) Tissue Pathology biopsy report
308
1984
1.82
15.49
2.7
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
132
2458
0.46
15.36
3.7
3.9
%
21.4
24.4
1.37
56
1213
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
113
505
2.41
15.36
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
380
5100
0.57
15.14
4.1
4.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
252
1539
1.87
14.96
3.2
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
418
2966
1.74
14.94
5.8
3.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
78
4.62
14.81
1.4
1.7
g/l
0.9
1.0
0.07
23
62
(3009542) Hematocrit [Volume Fraction] of Blood
467
5912
0.58
14.59
39.5
16.2
%
34.4
39.0
15.59
275
3626
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
205
3234
0.53
14.14
2.3
2.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
189
3019
0.53
13.37
3.6
4.0
ug/l
3.0
2.2
0.63
143
2679
(3023183) Ammonium ion [Moles/volume] in Plasma
50
156
3.33
13.31
1.5
2.5
umol/l
38.1
33.3
0.63
34
133
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
577
6853
0.59
13.03
40.9
14.4
mg/l
43.3
25.7
20.52
556
5430
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
226
3401
0.56
12.86
2.1
2.1
pmol/l
96.1
93.0
0.36
135
1732
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
21
8.23
12.78
1.1
2.2
e6/l
2617.4
360.3
0.60
12
16
(3012501) Base excess in Blood by calculation
46
144
3.31
12.19
4.7
4.8
mmol/l
2.6
2.9
0.31
35
97
(3012516) Albumin [Mass/volume] in Urine
153
2527
0.53
11.71
2.5
3.2
mg/l
172.5
207.0
0.13
89
1604
(3009508) Creatinine [Moles/volume] in Urine
162
2572
0.55
10.60
2.5
3.1
mmol/l
6.7
7.3
1.21
127
2142
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
172
2672
0.56
10.36
2.1
3.1
ng/l
1600.9
1704.7
0.10
155
2296
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
190
2869
0.58
10.28
2.2
2.2
nmol/l
67.3
78.4
5.98
172
2473
(3002385) Erythrocyte distribution width [Ratio]
440
5449
0.64
10.25
49.4
17.3
%
15.3
13.8
49.46
431
5282
(1761868) Lipid panel - Serum or Plasma
115
2006
0.51
10.24
3.1
3.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
10
11.12
10.18
1.2
3.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
13
16
8.22
9.75
1.1
2.6
e6/l
677.3
130230.3
—
7
8
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
48
178
2.79
9.54
2.2
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
178
2685
0.58
9.39
3.4
3.9
mg/mmol
27.1
8.2
1.41
98
1704
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
1027
0.38
9.09
1.1
1.3
u/ml
21.2
16.0
0.11
15
360
(3026493) Urate [Moles/volume] in Serum or Plasma
111
1897
0.53
9.09
2.4
2.5
umol/l
342.3
8260.2
7.94
82
1590
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
70
322
2.27
8.88
1.7
1.6
ug/l
3.3
1.8
0.34
64
278
(3044007) Cell count panel - Peritoneal fluid
12
15
8.09
8.87
1.1
2.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
12
15
8.09
8.87
1.1
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
226
1537
1.62
8.53
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
96
1686
0.52
8.53
2.6
2.8
ug/l
0.6
0.8
3.24
61
1191
(3026782) Osmolality of Urine
211
1411
1.64
8.52
3.0
2.6
mosm/kgh2o
546.6
547.6
0.02
189
1176
(3003458) Phosphate [Moles/volume] in Serum or Plasma
153
951
1.73
8.11
2.8
4.4
mmol/l
1.0
1.0
0.13
140
858
(3010421) pH of Blood
46
182
2.61
8.10
4.7
4.4
ph
7.4
7.4
0.10
46
141
(4062490)
20
47
4.33
7.96
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
47
4.33
7.96
1.1
1.2
g/l
6.2
8.0
0.82
11
35
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
47
4.33
7.96
1.1
1.2
g/l
0.6
0.4
0.65
11
35
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
47
4.33
7.96
1.1
1.2
g/l
3.5
2.8
1.25
11
35
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
1075
0.44
7.89
1.1
1.3
iu/ml
56.8
41.5
0.27
13
334
(3006922) Hepatitis E virus Ab [Presence] in Serum
14
24
5.91
7.87
1.1
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
101
3.14
7.76
3.9
2.8
%
60.4
59.9
0.09
31
101
(3021960) Folate [Moles/volume] in Serum or Plasma
127
2005
0.58
7.69
1.6
1.6
nmol/l
21.2
20.5
0.24
117
1684
(3023199) Leukocytes [#/volume] in Pleural fluid
28
88
3.25
7.44
1.2
1.4
e6/l
2906.4
1519.3
0.42
22
62
(4281824)
16
33
4.92
7.43
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
1011
0.44
7.41
10.7
7.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
79
3.36
7.28
1.2
1.5
e6/l
49131.6
121988.3
0.38
16
42
(3019150) Specific gravity of Urine by Refractometry
98
1630
0.55
7.11
3.7
4.1
kg/l
1.0
1.0
0.23
17
247
(3011397) Hemoglobin [Presence] in Urine by Test strip
105
1705
0.57
6.97
3.7
3.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
24
73
3.35
6.72
1.3
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
280
2096
1.48
6.62
5.7
3.1
ph
7.4
7.4
0.36
75
333
(40758558) Short blood count panel - Blood
216
1534
1.53
6.58
22.1
4.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
106
636
1.75
6.34
2.7
5.6
mmol/l
8.8
11.3
2.54
96
599
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
23
5.27
6.02
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
23
5.27
6.02
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
283
2164
1.44
5.87
3.2
3.1
e6/l
25.2
89.5
1.39
237
1659
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
97
2.84
5.77
3.1
2.5
e9/l
4.5
4.6
0.12
27
97
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
24
612
0.38
5.68
3.6
3.4
ng/l
137.6
92.1
1.07
18
529
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
82
473
1.80
5.61
2.0
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
116
743
1.64
5.45
6.5
3.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
540
1.74
5.39
7.0
2.8
mmol/l
1.2
1.2
0.54
80
445
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
402
3312
1.37
5.28
6.7
5.1
mmol/l
1.2
1.2
4.00
381
2918
(3030467) Casts [#/volume] in Urine by Automated count
258
1974
1.42
5.25
3.3
3.0
e6/l
0.7
0.4
1.32
215
1485
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
24
87
2.80
5.07
5.5
6.7
mg/l
10.9
12.0
0.61
19
77
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
181
1305
1.48
5.02
1.9
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
399
1.82
5.00
9.1
9.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
977
0.54
4.91
3.6
5.1
%
33.3
33.2
0.02
34
637
(3018572) Chloride [Moles/volume] in Blood
39
182
2.19
4.87
8.4
6.4
mmol/l
104.9
105.3
0.15
34
171
(3039000) Anion gap in Blood
39
182
2.19
4.87
8.4
6.4
mmol/l
10.9
11.0
0.14
34
171
(3021601) Nitrite [Presence] in Urine by Test strip
275
3426
0.72
4.87
4.7
5.0
estimate
0.0
0.0
0.00
80
579
(3035350) Ketones [Presence] in Urine by Test strip
276
3432
0.72
4.81
3.5
3.7
estimate
0.0
0.0
0.00
80
586
(3002032) Base excess in Venous blood by calculation
112
737
1.59
4.72
3.1
3.0
mmol/l
1.7
2.1
0.49
93
592
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
97
2.62
4.67
1.2
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
112
741
1.58
4.62
3.1
3.0
kpa
5.6
5.9
2.40
106
711
(3012544) pH of Venous blood
115
766
1.57
4.60
3.2
3.1
—
7.4
—
0
5
(3004588) Protein electrophoresis panel - Serum or Plasma
24
555
0.42
4.55
1.7
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
59
3.09
4.53
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
282
3463
0.73
4.43
3.5
3.8
estimate
0.0
0.0
0.50
75
573
(3051651) Icteric interference index of Serum or Plasma
12
31
3.91
4.26
6.5
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
84
529
1.65
4.24
3.2
4.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
836
0.54
4.22
2.1
2.5
ug/l
2.2
7.1
13.64
42
719
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
336
0.29
4.17
1.3
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
241
1889
1.37
4.13
3.3
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
495
4312
1.31
4.10
7.2
4.4
mmol/l
8.0
6.9
13.34
477
4035
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
18
63
2.89
4.08
1.1
1.2
nmol/l
0.9
1.4
1.03
13
54
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
428
3665
1.31
3.97
7.2
5.5
mmol/l
1.2
1.2
2.13
339
3104
(3012441) Differential panel - Pleural fluid
19
70
2.75
3.94
1.2
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
12
33
3.67
3.93
1.1
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
197
1506
1.39
3.92
2.5
2.4
e6/l
7.3
4.9
0.88
180
1303
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
38
3.46
3.91
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
145
2.18
3.90
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
600
0.48
3.89
1.5
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
690
0.52
3.88
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
65
2.80
3.87
1.3
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
136
975
1.46
3.86
1.9
2.5
%
21.4
22.8
0.42
120
815
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
29
133
2.22
3.83
1.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
238
1.89
3.76
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
268
0.33
3.74
1.1
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
84
2.53
3.73
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
130
931
1.46
3.71
1.8
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
95
639
1.54
3.67
4.7
6.1
mmol/l
1.6
1.5
0.28
90
609
(3001122) Ferritin [Mass/volume] in Serum or Plasma
222
2763
0.74
3.65
2.3
2.7
ug/l
295.0
141.0
5.48
202
2486
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
9
7.83
3.56
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
25
513
0.47
3.51
1.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
129
934
1.44
3.48
1.9
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
91
614
1.53
3.47
2.7
2.5
kpa
4.5
4.4
0.18
85
585
(3017446) Testosterone [Moles/volume] in Serum or Plasma
14
359
0.38
3.43
1.7
2.3
nmol/l
11.6
14.8
0.66
14
311
(3047181) Lactate [Moles/volume] in Blood
45
253
1.82
3.43
8.2
6.0
mmol/l
1.5
1.3
0.80
38
232
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
38
673
0.55
3.39
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
32
3.47
3.34
1.3
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
32
3.47
3.34
1.3
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
267
2186
1.31
3.33
4.2
5.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
77
2.50
3.31
1.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
677
0.56
3.25
3.7
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
138
1817
0.72
3.21
1.5
1.8
pmol/l
513.7
17575358.8
1.28
108
1468
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
221
0.31
3.21
1.4
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
20
85
2.38
3.17
2.0
2.0
%
89.2
89.9
0.22
20
85
(3045414) Leukocytes [Presence] in Urine
11
302
0.36
3.15
1.5
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
88
606
1.50
3.07
5.6
7.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
134
1757
0.72
3.03
1.9
1.8
nmol/l
1290.8
1176.6
0.73
110
1312
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
51
2.77
2.99
1.4
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
40
3.03
2.98
1.3
1.3
—
—
—
0
0
(4010399)
30
544
0.54
2.92
1.1
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
50
787
0.61
2.88
1.1
1.3
titre
502.9
545.1
—
7
193
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
13
5.42
2.87
1.1
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
83
2.32
2.85
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
93
2.18
2.62
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
14
314
0.44
2.55
1.0
1.2
iu/ml
288.2
122.3
—
6
115
(3002173) Hemoglobin [Mass/volume] in Arterial blood
101
743
1.40
2.53
7.2
7.2
g/l
114.2
121.3
3.53
95
720
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
109
2.04
2.47
4.0
2.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
292
2496
1.25
2.47
3.6
3.5
e6/l
65.1
113.8
1.08
239
1786
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
103
2.06
2.43
1.3
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
189
0.37
2.43
1.1
1.2
—
39.9
—
0
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
83
2.19
2.42
1.3
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
303
2613
1.24
2.35
3.3
3.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
140
1.88
2.34
2.1
2.5
%
14.3
16.4
—
7
71
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
217
0.41
2.33
1.3
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
133
1.90
2.33
2.1
3.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
177
1.78
2.32
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
177
1.78
2.32
1.5
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
154
0.32
2.29
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
183
0.38
2.16
1.1
1.2
—
3.8
—
0
30
(40768797) Stomach Pathology biopsy report
121
943
1.32
2.13
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
29
482
0.59
2.13
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
106
810
1.35
2.13
7.0
6.8
%
96.5
94.9
3.35
100
785
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
328
0.51
2.08
1.7
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
82
2.09
2.07
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
31
2.92
2.07
1.0
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
55
376
1.49
2.06
2.9
2.3
%
0.7
0.6
0.56
55
365
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
15
4.02
2.04
1.2
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
178
0.39
2.04
1.1
1.2
—
2.8
—
0
19
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
145
0.34
2.02
1.2
1.6
—
—
—
0
0
(4034850)
13
269
0.48
1.97
12.2
10.8
—
—
—
0
0
(3013512) EKG study
198
2333
0.81
1.92
3.8
4.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
265
0.48
1.89
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
64
460
1.42
1.87
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
72
2.10
1.87
1.0
1.3
u/ml
111.4
110.4
—
5
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
143
1163
1.27
1.84
3.2
2.8
e6/l
3.1
2.4
0.25
86
638
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
228
2636
0.82
1.83
3.7
4.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
35
2.59
1.80
1.2
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
45
649
0.68
1.79
1.2
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
46
658
0.68
1.76
1.3
2.0
ug/g
104.5
170.6
1.41
36
509
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
441
1.41
1.74
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
9
36
2.51
1.74
1.2
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
194
0.46
1.74
4.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
114
910
1.29
1.71
6.6
6.5
mmol/l
0.9
1.4
0.65
95
706
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
48
0.00
1.70
0.0
1.1
—
4.2
—
0
10
(3024263) Appearance of Synovial fluid
0
49
0.00
1.68
0.0
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
277
3124
0.84
1.68
3.3
4.1
ng/l
51.0
76.0
0.44
231
2359
(3007930) Methemoglobin/Hemoglobin.total in Blood
48
335
1.46
1.67
7.5
4.5
%
1.0
0.9
0.61
43
323
(3032057) Clostridioides difficile [Presence] in Stool
6
19
3.17
1.66
2.0
2.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
149
0.40
1.64
1.2
1.2
—
8.8
—
0
12
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
103
1284
0.78
1.63
1.2
1.2
u/ml
0.9
1.5
1.21
21
327
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
113
908
1.28
1.62
6.7
6.5
kpa
5.0
5.1
1.11
106
873
(3027801) Oxygen [Partial pressure] in Arterial blood
113
908
1.28
1.62
6.7
6.5
kpa
13.7
11.2
4.19
105
871
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
84
1.92
1.60
1.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
20
3.01
1.58
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
129
1.72
1.57
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
44
308
1.45
1.52
1.1
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
43
0.00
1.52
0.0
1.2
—
1.1
—
0
25
(3014051) Protein [Presence] in Urine by Test strip
9
182
0.49
1.52
1.6
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
454
4891
0.86
1.50
3.7
4.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
217
0.50
1.50
3.9
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
48
343
1.42
1.49
7.5
4.4
%
1.8
1.8
0.10
43
331
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
16
3.14
1.44
1.0
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
564
5303
1.16
1.43
28.0
5.2
u/l
204.3
77.2
38.34
548
4847
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
251
0.55
1.42
1.1
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
40
2.26
1.40
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
124
0.40
1.37
1.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
72
559
1.31
1.36
5.8
4.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
88
1090
0.79
1.34
1.3
1.3
g/l
2.5
2.8
1.22
50
600
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
41
0.00
1.31
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
41
0.00
1.31
0.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
21
129
1.64
1.30
1.9
2.2
%
70.2
61.9
1.10
21
129
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
116
1385
0.81
1.28
1.6
1.6
mg/l
3.2
1.3
3.37
102
1076
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
172
1978
0.84
1.28
2.0
2.2
mg/l
3.1
3.0
0.19
154
1660
(3017181) Myelocytes/100 leukocytes in Blood
64
496
1.31
1.24
2.4
3.7
%
1.2
0.8
0.73
41
109
(3002030) Lymphocytes/100 leukocytes in Blood
336
3067
1.15
1.24
4.2
5.4
%
20.4
26.3
15.88
314
2800
(3021589) Normoblasts [#/volume] in Blood
263
2917
0.86
1.24
19.7
8.5
e9/l
0.0
0.0
0.51
208
2362
(3008152) Bicarbonate [Moles/volume] in Arterial blood
69
541
1.30
1.23
7.4
6.5
mmol/l
24.5
24.5
0.00
62
512
(40768800) Prostate Pathology biopsy report
9
45
2.01
1.23
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
189
0.52
1.23
1.6
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
142
0.49
1.21
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
1.3
—
40.4
—
0
7
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
39
2.06
1.15
1.4
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
330
3023
1.14
1.15
4.2
5.5
%
8.5
8.9
0.78
312
2778
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
65
1.86
1.13
6.7
2.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
113
0.44
1.13
1.0
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
245
0.61
1.12
1.3
1.6
—
150.9
—
0
11
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
268
1.40
1.12
1.1
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
428
4004
1.13
1.05
5.2
3.0
u/l
267.2
50.8
20.03
401
3633
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
163
1.48
1.02
1.3
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
26
180
1.46
1.01
4.6
2.9
mmol/l
9.9
7.7
2.68
26
174
(3037756) Immunofixation for Serum or Plasma
9
157
0.57
0.99
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
159
0.56
0.99
1.0
1.1
—
13.8
—
0
10
(3022096) Basophils/100 leukocytes in Blood
317
2923
1.13
0.98
4.2
5.3
%
0.6
0.7
2.81
300
2684
(3022689) Creatine [Moles/volume] in Urine
0
30
0.00
0.97
0.0
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
174
0.57
0.97
1.8
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
326
3013
1.13
0.97
4.1
5.3
%
2.3
3.0
5.91
309
2761
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
32
0.00
0.95
0.0
1.2
—
37.4
—
0
16
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
32
0.00
0.95
0.0
1.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.1
—
14.4
—
0
7
(3023520) Reticulocytes [#/volume] in Blood
57
709
0.79
0.95
2.0
2.2
e9/l
67.0
68.1
0.06
46
560
(40760892) CBC W Ordered Manual Differential panel - Blood
145
1270
1.17
0.94
3.5
4.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
27
192
1.42
0.93
4.5
2.7
mmol/l
2.0
1.7
0.36
27
186
(3002179) Metamyelocytes/100 leukocytes in Blood
57
456
1.27
0.92
2.6
3.7
%
0.7
0.5
0.21
32
84
(3022621) pH of Urine by Test strip
38
494
0.76
0.90
2.1
3.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
153
0.58
0.89
1.8
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
128
0.54
0.88
1.1
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
130
0.54
0.88
1.1
1.2
—
31.8
—
0
14
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
87
736
1.20
0.85
1.9
2.8
u/l
255.1
241.4
0.30
81
687
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
112
0.53
0.83
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
43
337
1.29
0.83
5.4
4.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
146
1.45
0.83
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
224
1.35
0.81
4.7
4.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.2
—
20.8
—
0
6
(3003129) Base excess in Capillary blood by calculation
0
24
0.00
0.79
0.0
1.3
—
0.4
—
0
24
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
48
1.67
0.79
6.3
2.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
50.2
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
74
1.63
0.78
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
82
1.59
0.78
2.4
2.6
—
—
—
0
0
(44806420)
6
34
1.77
0.76
2.2
2.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
23
166
1.40
0.76
1.0
1.2
—
715.0
—
0
6
(44790049)
11
67
1.65
0.75
1.1
1.4
—
—
—
0
0
(44806118)
11
67
1.65
0.75
1.1
1.4
—
—
—
0
0
(44790047)
11
67
1.65
0.75
1.1
1.4
—
—
—
0
0
(44790048)
11
67
1.65
0.75
1.1
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
75
1.61
0.75
1.0
1.1
u/ml
272.5
277.5
—
6
41
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
170
1875
0.89
0.73
3.6
4.1
estimate
0.0
0.0
0.50
69
558
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
238
1.31
0.71
2.4
3.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
69
1.60
0.68
2.0
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
57
475
1.21
0.68
2.5
3.7
%
0.1
0.0
0.80
39
99
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
215
0.69
0.68
2.6
2.4
ug/min
106.6
108.5
—
10
135
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
138
1242
1.13
0.65
3.1
2.6
e6/l
1.4
1.2
0.24
81
714
(3037121) Protein [Mass/volume] in Urine
18
247
0.72
0.65
1.4
2.3
g/l
0.5
0.3
—
8
79
(3018010) Neutrophils/100 leukocytes in Blood
322
3039
1.09
0.61
4.0
5.3
%
63.2
58.4
7.51
303
2796
(3052851) Hemolysis interference index of Serum or Plasma
27
209
1.30
0.61
5.7
3.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
10.2
—
0.6
—
0
20
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
1837.1
—
0
21
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
21
0.00
0.60
0.0
1.0
—
1.1
—
0
8
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
23
0.00
0.58
0.0
1.3
—
1.0
—
0
17
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
136.5
—
0
23
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
39
319
1.23
0.58
1.8
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
81
1.49
0.57
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
81
1.49
0.57
1.0
1.3
nmol/l
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
46
384
1.21
0.57
4.0
3.2
%
51.6
46.9
0.67
46
375
(3025159) Blasts/100 leukocytes in Blood
53
451
1.19
0.54
2.6
3.8
%
0.0
1.0
0.48
34
88
(3024928) Oxygen saturation in Venous blood
22
169
1.31
0.53
2.4
2.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
62
1.46
0.53
1.3
1.9
%
12.7
10.7
—
9
62
(3017732) Neutrophils [#/volume] in Blood
35
424
0.82
0.52
4.2
3.1
e9/l
3.8
4.1
0.25
28
294
(3023419) Bacteria identified in Sputum by Culture
6
96
0.62
0.52
2.8
2.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
100
0.60
0.52
1.0
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
47
400
1.18
0.49
1.5
2.0
g/l
10.0
11.1
1.02
36
365
(3007853) Bacteria identified in Skin by Aerobe culture
70
790
0.88
0.47
1.5
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
82
0.61
0.46
3.0
3.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
83
0.60
0.46
1.2
1.2
—
76.1
—
0
6
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
31
1.62
0.43
1.4
1.1
u/l
28.6
21.8
—
5
25
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
56
1.43
0.42
1.3
2.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
138
0.72
0.40
1.9
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
31
368
0.84
0.40
1.6
3.5
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
0.5
—
0
8
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
35
1.43
0.39
1.4
1.1
u/l
246.8
101.2
—
5
28
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
106
1.33
0.39
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
19
0.00
0.39
0.0
2.1
—
2.9
—
0
6
(3000285) Sodium [Moles/volume] in Blood
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
462
0.86
0.38
1.8
3.4
mmol/l
2.6
1.9
0.35
28
347
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
197
1.22
0.38
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
197
1.22
0.38
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
42
481
0.87
0.37
1.8
3.4
ph
7.5
7.4
—
6
54
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
43
490
0.87
0.35
1.8
3.4
kpa
5.0
5.2
1.01
37
452
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
200
1.21
0.34
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
532
1.12
0.32
1.7
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
62
563
1.11
0.30
1.3
1.7
%
1.8
1.6
0.69
45
464
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
55
1.27
0.30
1.0
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
223
2326
0.95
0.29
3.0
3.3
—
—
—
0
0
(4146454)
8
107
0.75
0.29
2.0
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
117
1246
0.93
0.29
14.8
29.7
inr
1.1
1.5
3.49
20
176
(3003327) Ova and parasites identified in Stool by Light microscopy
14
173
0.81
0.28
1.7
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
85
1.30
0.28
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
70
760
0.91
0.27
1.6
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
509
1.11
0.27
2.1
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
76
1.19
0.24
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
558
0.91
0.24
6.0
2.4
ml/min/173m2
62.4
61.6
0.07
24
229
(3011288) Drugs identified in Urine by Screen method
5
42
1.19
0.21
1.0
1.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
89.4
—
0
11
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
14.6
—
0
12
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
49.8
—
0
12
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
6.9
—
0
7
(3036071) Salmonella sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
297
1.12
0.20
1.8
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
80
1.25
0.20
1.1
1.2
—
—
—
0
0
(4133840)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
50
1.20
0.19
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
260
1.12
0.19
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
81
1.24
0.19
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
259
0.89
0.18
2.5
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
82
1.22
0.17
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
67
0.74
0.17
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
67
0.74
0.17
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
67
0.74
0.17
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
68
0.73
0.17
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
153
1583
0.96
0.16
3.1
4.2
ng/l
79.4
376.3
4.73
119
1353
(3000330) Specific gravity of Urine by Test strip
40
429
0.93
0.14
4.5
3.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
30
326
0.92
0.14
1.4
1.3
g/l
1.0
1.2
0.34
25
297
(3019225) pH of Specimen
72
755
0.95
0.13
2.7
3.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
11
94
1.17
0.13
4.4
7.6
mmol/l
7.9
7.8
0.01
11
79
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
219
1.10
0.12
1.8
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
179
0.89
0.12
1.4
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
125
0.88
0.10
1.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
44
1.14
0.10
1.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
107
1.12
0.08
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
65
0.77
0.08
1.2
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
358
0.95
0.08
1.3
1.6
g/l
1.6
1.5
0.19
28
312
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
41
428
0.96
0.07
2.4
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
95
0.84
0.06
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
332
3352
0.99
0.06
4.2
5.2
e9/l
0.2
0.2
2.38
285
2898
(3027945) Reticulocytes/100 erythrocytes in Blood
94
957
0.98
0.04
1.7
2.0
%
1.9
1.8
0.40
89
832
(3001604) Monocytes [#/volume] in Blood
325
3230
1.01
0.03
3.9
5.1
e9/l
0.7
0.6
1.31
271
2735
(3041096) Erythrocytes [Presence] in Urine by Automated
176
1745
1.01
0.03
3.2
3.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
103
1.07
0.02
1.3
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
326
3249
1.01
0.01
3.9
5.1
e9/l
0.0
0.0
0.16
273
2757
(3019198) Lymphocytes [#/volume] in Blood
331
3301
1.00
0.01
4.1
5.2
e9/l
1.5
1.8
8.57
288
2851
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
144
1.04
0.00
1.1
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
471
4703
1.00
0.00
4.5
4.6
e6/l
11.9
2495.0
—
7
79
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
416
1.01
0.00
1.2
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
25
252
0.99
0.00
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
107
1.03
0.00
1.4
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
51
0.98
0.00
2.8
2.9
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
9
0.00
0.00
0.0
2.0
—
0.8
—
0
9
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
79
0.89
0.00
1.3
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
52
0.96
0.00
1.2
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
19.5
—
0
6
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
57
0.88
0.00
1.2
1.2
iu/l
42.4
27.6
—
5
49
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
5.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
7.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
51
0.98
0.00
1.2
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_ADENO_EXALLC – Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).